These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Anti-cyclic citrullinated peptide antibodies are not associated with familial Mediterranean fever.
    Author: Karatay S, Yildirim K, Erdal A, Uzkeser H, Erdem FH, Yanmaz V.
    Journal: J Back Musculoskelet Rehabil; 2010; 23(1):21-3. PubMed ID: 20231785.
    Abstract:
    OBJECTIVE: This study investigated the presence of anti-cyclic citrullinated peptide (anti-CCP) antibodies in familial Mediterranean fever (FMF) patients and controls. MATERIAL AND METHODS: Forty-nine patients with FMF were enrolled (23 had a history of arthritis during attacks and 26 had no such history). Two control groups were enrolled: 20 patients with rheumatoid arthritis (RA) and 30 healthy individuals. Clinical and laboratory assessments of the FMF patients were performed during attack-free periods. Erythrocyte sedimentation rate (ESR), serum C-reactive protein (CRP), rheumatoid factor (RF), and anti-CCP antibody levels were measured. RESULTS: In RA patients' ESR and CRP levels, frequency of RF, and anti-CCP antibody levels were significantly higher than in both FMF patients and healthy controls (p 0.001). Moreover, anti-CCP was negative in all healthy controls as well as in all FMF patients. CONCLUSION: Our results show that anti-CCP antibodies are not associated with FMF.
    [Abstract] [Full Text] [Related] [New Search]